Source:http://linkedlifedata.com/resource/pubmed/id/21327939
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2011-8-5
|
pubmed:abstractText |
Expansion of transplantable cord blood (CB) progenitors using a stroma requires provision of an exogenous cell source because of the low frequency of stromal precursor cells in CB. A simpler approach from a clinical regulatory perspective would be to provide synthetic extracellular matrix. The aim of this study was to characterize the effect on hematopoietic cell culture of fucoidan. The modulation of cytokine-driven hematopoietic cell expansion by fucoidan was investigated using two-level fractional and full factorial experimental designs. Mobilized peripheral blood (PB) CD34(+) cells were grown over 10 days in various combinations of FL, SCF, TPO, G-CSF, and SDF-1. Cultures were analyzed by immunophenotype. The effect of fucoidan on the divisional recruitment of CD34(+) cells was studied by CFDA-SE division tracking. Fucoidan was adsorbed by polystyrene to tissue culture plates and promoted formation of an adherent hematopoietic culture. Factorial design experiments with mobilized PB-CD34(+) cells showed that fucoidan reduced the production of CD34(+) cells and CD34(+)CXCR4(+) ratio but did not affect the production of monocytic, granulocytic, or megakaryocytic cells. The inhibitory effect of fucoidan on expansion of CB-CD34(+) cells was greater than mobilized PB. Division tracking analysis showed that CD34(+) cell generation times were lengthened by fucoidan. Fucoidan binds growth factors via their heparin-binding domain. The formation of an adherent hematopoietic culture system by fucoidan is most likely mediated by the binding of L-selectin and integrin-?M?2 on myeloids. Fucoidan deserves further investigation as glycan scaffold that is suitable for immobilization of other matrix molecules thought to comprise blood stem cell niche.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL12,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Stem Cell Factor,
http://linkedlifedata.com/resource/pubmed/chemical/fucoidan
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1432-0584
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1005-15
|
pubmed:meshHeading |
pubmed-meshheading:21327939-Antigens, CD34,
pubmed-meshheading:21327939-Antineoplastic Agents,
pubmed-meshheading:21327939-Cell Adhesion,
pubmed-meshheading:21327939-Cell Culture Techniques,
pubmed-meshheading:21327939-Cell Proliferation,
pubmed-meshheading:21327939-Cells, Cultured,
pubmed-meshheading:21327939-Chemokine CXCL12,
pubmed-meshheading:21327939-Hematopoietic Stem Cells,
pubmed-meshheading:21327939-Humans,
pubmed-meshheading:21327939-Megakaryocytes,
pubmed-meshheading:21327939-Polysaccharides,
pubmed-meshheading:21327939-Stem Cell Factor
|
pubmed:year |
2011
|
pubmed:articleTitle |
Formation of an adherent hematopoietic expansion culture using fucoidan.
|
pubmed:affiliation |
Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW 2052, Australia. mohammad.irhimeh@sydney.edu.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|